Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Cydy pulling out of Hiv MDR

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Oct 30, 2022 3:59pm

98 Views

Post# 35058689

RE:RE:Cydy pulling out of Hiv MDR

We once again got mentioned in Montreal paper La Presse business section... for new 52 week low short list and the following comment: companies having a hard time lately. So this is the publicity we get atm.... a company hitting new lows and that is having difficulties.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"